Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation
Clinical Hematology International · 2019 · 2 (1) · 2
DOI: 10.2991/chi.d.191207.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Hematology International, 2019. Verfasst von Abraham S Kanate und 2 weiteren Autor:innen. Beteiligte Einrichtung: Hematopoietic Malignancy and Cellular Therapy, West Virginia University Cancer Institute, Morgantown, WV, USA. Die Arbeit wurde bisher 102-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hematopoietic Malignancy and Cellular Therapy, West Virginia University Cancer Institute, Morgantown, WV, USA.
- Chaim Sheba Medical Center, Tel Aviv University, Tel-Hashomer, Ramat Gan, Israel.
- Department of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Zitieren
APA
Kanate, A. S., Nagler, A., & Savani, B. (2019). Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation. Clinical Hematology International, 2(1), 2. https://doi.org/10.2991/chi.d.191207.001
Vancouver
Kanate AS, Nagler A, Savani B. Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation. Clinical Hematology International. 2019;2(1):2. doi:10.2991/chi.d.191207.001
BibTeX
@article{Kanate2019,
author = {Kanate, Abraham S and Nagler, Arnon and Savani, Bipin},
title = {Summary of Scientific and Statistical Methods, Study Endpoints and Definitions for Observational and Registry-Based Studies in Hematopoietic Cell Transplantation},
journal = {Clinical Hematology International},
year = {2019},
volume = {2},
number = {1},
pages = {2},
doi = {10.2991/chi.d.191207.001}
}
EUVIMED